Kim O’Neill

1.6k citations

30 papers · 1.2k indexed · h-index 16

Impact in

Endocrine and Autonomic Systems top 2%
- Regulation of Appetite and Obesity
Nutrition and Dietetics top 2%
- Biochemical Analysis and Sensing Techniques

Papers in

Endocrine and Autonomic Systems 13
- Regulation of Appetite and Obesity 13
Nutrition and Dietetics 15
- Biochemical Analysis and Sensing Techniques 14

Co-authors: Brian E. Hawes Blair Weig Michael P. Graziano William J. Greenlee Beverly B. Green E. Helen Kemp David J. Gawkrodger Anthony P. Weetman
Journals: Bioorganic & Medicinal Chemistry Letters (8 papers)Bioorganic & Medicinal Chemistry (3 papers)Journal of Medicinal Chemistry (3 papers)ACS Medicinal Chemistry Letters (2 papers)Journal of Clinical Investigation (2 papers)
Partner nations: United States United Kingdom Ireland

In The Last Decade

Kim O’Neill

29 papers receiving 1.1k citations

Peers

Countries citing papers authored by Kim O’Neill

Since Specialization

Citations

This map shows the geographic impact of Kim O’Neill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim O’Neill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim O’Neill more than expected).

Fields of papers citing papers by Kim O’Neill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim O’Neill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim O’Neill. The network helps show where Kim O’Neill may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kim O’Neill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kim O’Neill Line = papers co-authored together Kim O’Neill links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Factor XIIa as a Novel Target for Thrombosis: Target Engagement Requirement and Efficacy in a Rabbit Model of Microembolic Signals Journal of Pharmacology and Experimental Therapeutics ·Christopher M. Barbieri, Xinkang Wang, Weizhen Wu, Robert Stanić, Aimie M. Ogawa, Kim O’Neill, Kaisu Savola, Gino Castriota, Dietmar Seiffert, David E. Gutstein, Zhu Chen	2016	11
2	Discovery of the oxazabicyclo[3.3.1]nonane derivatives as potent and orally active GPR119 agonists Bioorganic & Medicinal Chemistry Letters ·Xing Dai, Andrew W. Stamford, Hong Liu, Bernard R. Neustadt, Jushan Bai Carrion-i-Silvestre, Rozita Parpaee, Brian E. Hawes, Xiaoying Xu, Hana E. Baker, Kim O’Neill, Morgan Woods, Huadong Tang, William J. Greenlee	2015	5
3	Discovery of a nortropanol derivative as a potent and orally active GPR119 agonist for type 2 diabetes Bioorganic & Medicinal Chemistry Letters ·Yan Xia, Samuel Chackalamannil, William J. Greenlee, 沖田充司, Bernard R. Neustadt, Andrew W. Stamford, Christopher S. Shiprack, Xiaoying Xu, Hana E. Baker, Kim O’Neill, Morgan Woods, Brian E. Hawes, Rozita Parpaee	2011	34
4	Vascular-targeted photodynamic therapy with BF2-chelated Tetraaryl-Azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment British Journal of Cancer ·Annette T. Byrne, Aisling O’Connor, Michael J. Hall, Julie Murtagh, Kim O’Neill, Kathleen M. Curran, Wuxian Peng, Jacques Rousseau, Roger Lecomte, Sharon F. McGee, John J. Callanan, Donal F. O’Shea, William M. Gallagher	2009	86
5	Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells British Journal of Pharmacology ·Yun Ning, Kim O’Neill, Lan Hong, Long Pang, L X Shan, Brian E. Hawes, 梢井ノ上	2008	83
6	Synthesis of novel bicyclo[4.1.0]heptane and bicyclo[3.1.0]hexane derivatives as melanin-concentrating hormone receptor R1 antagonists Bioorganic & Medicinal Chemistry Letters ·Jing Su, 杨居礼, Brian A. McKittrick, Nick Brekke, Tao Guo, Gang Qian, Duane A. Burnett, John W. Clader, William J. Greenlee, Brian E. Hawes, Kim O’Neill, Brian D. Spar, Blair Weig, Timothy J. Kowalski, Steve Sorota	2007	5
7	SAR study of bicyclo[4.1.0]heptanes as melanin-concentrating hormone receptor R1 antagonists: Taming hERG Bioorganic & Medicinal Chemistry ·Jing Su, Brian A. McKittrick, 杨居礼, Duane A. Burnett, John W. Clader, William J. Greenlee, Brian E. Hawes, Kim O’Neill, Brian D. Spar, Blair Weig, Timothy J. Kowalski, Steve Sorota, Cheng Li, Tongtong Liu	2007	7
8	Bicyclic[4.1.0]heptanes as phenyl replacements for melanin concentrating hormone receptor antagonists Bioorganic & Medicinal Chemistry ·Ruo Xu, Shengjian Li, Rakesh Kundu, Mark D. McBriar, Henry Guzik, Anandan Palani, John W. Clader, Kathleen Cox, William J. Greenlee, Brian E. Hawes, Timothy J. Kowalski, Kim O’Neill, Brian D. Spar, Blair Weig, Daniel J. Weston	2006	22
9	Synthesis and structure–activity relationships of piperidine-based melanin-concentrating hormone receptor 1 antagonists Bioorganic & Medicinal Chemistry Letters ·Wen‐Lian Wu, Duane A. Burnett, S.K. Pandher, Qiang Li, Philipp Benzinger, Martin S. Domalski, William J. Greenlee, Kim O’Neill, Brian E. Hawes	2006	4
10	Bicyclo[3.1.0]hexyl urea melanin concentrating hormone (MCH) receptor-1 antagonists: Impacting hERG liability via aryl modifications Bioorganic & Medicinal Chemistry Letters ·Mark D. McBriar, Henry Guzik, Sherry Shapiro, Ruo Xu, Rakesh Kundu, John W. Clader, Kim O’Neill, Brian E. Hawes, Steve Sorota, Michael Margulis, Kristal R. Tucker, Daniel J. Weston, Kathleen Cox	2006	11
11	Design and synthesis of orally efficacious benzimidazoles as melanin-concentrating hormone receptor 1 antagonists Bioorganic & Medicinal Chemistry Letters ·Wen‐Lian Wu, Duane A. Burnett, Mary Ann Caplen, Martin S. Domalski, Chad Bennett, William J. Greenlee, Brian E. Hawes, Kim O’Neill, Blair Weig, Daniel J. Weston, Brian D. Spar, Timothy J. Kowalski	2006	12
12	Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice European Journal of Pharmacology ·Timothy J. Kowalski, Brian D. Spar, Blair Weig, Constance Farley, John A. Cook, Lorraine Ghibaudi, M. P�rez-Amor, Kim O’Neill, Robert A. Del Vecchio, Mark D. McBriar, Henry Guzik, John W. Clader, Brian E. Hawes, Joyce Hwa	2006	44
13	Novel aminobenzimidazoles as selective MCH-R1 antagonists for the treatment of metabolic diseases Bioorganic & Medicinal Chemistry Letters ·Philipp Benzinger, Qiang Li, Duane A. Burnett, William J. Greenlee, Brian E. Hawes, Timothy J. Kowalski, Kim O’Neill, Brian D. Spar, Blair Weig	2006	15
14	Biaryl Ureas as Potent and Orally Efficacious Melanin Concentrating Hormone Receptor 1 Antagonists for the Treatment of Obesity Journal of Medicinal Chemistry ·Anandan Palani, Sherry Shapiro, Mark D. McBriar, John W. Clader, William J. Greenlee, Brian D. Spar, Timothy J. Kowalski, Constance Farley, John A. Cook, Margaret van Heek, Blair Weig, Kim O’Neill, Michael P. Graziano, Brian E. Hawes	2005	54
15	Biaryl diamides as potent melanin concentrating hormone receptor 1 antagonists Bioorganic & Medicinal Chemistry Letters ·Anandan Palani, Sherry Shapiro, Mark D. McBriar, John W. Clader, William J. Greenlee, Kim O’Neill, Brian E. Hawes	2005	12
16	Discovery of melanin-concentrating hormone receptor R1 antagonists using high-throughput synthesis Bioorganic & Medicinal Chemistry ·Jing Su, Brian A. McKittrick, 杨居礼, Michael Czarniecki, William J. Greenlee, Brian E. Hawes, Kim O’Neill	2004	23
17	The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo Journal of Clinical Investigation ·E. Helen Kemp, Elizabeth A. Waterman, Brian E. Hawes, Kim O’Neill, Raju V.S.R.K. Gottumukkala, David J. Gawkrodger, Anthony P. Weetman, Philip F. Watson	2002	96
18	The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo Journal of Clinical Investigation ·E. Helen Kemp, Elizabeth A. Waterman, Brian E. Hawes, Kim O’Neill, Raju V.S.R.K. Gottumukkala, David J. Gawkrodger, Anthony P. Weetman, Philip F. Watson	2002	87
19	Cloning and characterization of rhesus monkey MCH-R1 and MCH-R2 Peptides ·Steven D.E. Fried, Kim O’Neill, Brian E. Hawes	2002	21
20	Identification and Pharmacological Characterization of a Novel Human Melanin-concentrating Hormone Receptor, MCH-R2 Journal of Biological Chemistry ·Suke Wang, I Misselwitz, Kim O’Neill, Blair Weig, Steven D.E. Fried, Thomas M. Laz, Marvin Bayne, Eric L. Gustafson, Brian E. Hawes	2001	89

About Kim O’Neill

Kim O’Neill is a scholar working on Endocrine and Autonomic Systems, Nutrition and Dietetics, Cellular and Molecular Neuroscience, Internal Medicine and Endocrinology, Diabetes and Metabolism, having authored 30 papers that have together received 1.2k indexed citations. Recurring topics across this work include Biochemical Analysis and Sensing Techniques (14 papers), Regulation of Appetite and Obesity (13 papers), Receptor Mechanisms and Signaling (12 papers), Adipose Tissue and Metabolism (5 papers), Diabetes Treatment and Management (4 papers), melanin and skin pigmentation (3 papers), Neuropeptides and Animal Physiology (3 papers) and Neuroscience and Neuropharmacology Research (2 papers). The work is most often cited by research in Endocrine and Autonomic Systems (417 citations), Nutrition and Dietetics (374 citations), Cell Biology (173 citations), Pharmacology (148 citations) and Cellular and Molecular Neuroscience (129 citations). Kim O’Neill has collaborated with scholars based in United States, United Kingdom and Ireland. Frequent co-authors include Brian E. Hawes, Blair Weig, Michael P. Graziano, William J. Greenlee, Beverly B. Green, E. Helen Kemp, David J. Gawkrodger, Anthony P. Weetman, Raju V.S.R.K. Gottumukkala and Elizabeth A. Waterman. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Bioorganic & Medicinal Chemistry, Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact